Pseudoscience has recently re-emerged in the U.S. While much of it concerns vaccines, an "oldie" is again making the rounds: ...

Just when you thought you had enough to worry about, scientists came up with a new world-ending anxiety for us all. A dire warning about something nobody outside the relevant fields knew anything ...

She will never forget it. The following year a second protease inhibitor to treat HIV became available. Those two medications turned around the numbers of not only new HIV cases and dramatically ...

Efforts to elucidate the HIV life cycle, aided by the genome sequence of the virus, revealed that a virally encoded aspartyl protease was crucial in viral replication. Specific design of protease ...

Peptide bonds can withstand hours in boiling concentrated acid, yet they last no more than microseconds in the presence of a specific protease. The study of proteolysis goes back at least to the ...

The four main classes, which most people are treated with, target one of three viral proteins which control HIV’s lifecycle: reverse transcriptase, integrase and protease. Historically, most people ...

The therapeutic, dubbed S-892216, leverages protease inhibitor technology to block the main ... used in treatments for diseases such as human immunodeficiency virus (HIV) and hepatitis C. Unlike ...

Lupin gained 3.66% to Rs 2,188 after the company announced that it has received a tentative approval from the U.S. Food and Drug Administration (USFDA) for its ANDA for Darunavir, Cobicistat, ...